PCSK9 has been studied in relation to Alzheimer's disease (AD) pathogenesis.[14,15] Initial findings suggest that PCSK9 promotes neuronal death and exacerbates beta‐amyloid (Aβ)‐induced neurotoxicity. This evidence concerns the gene PCSK9 and early-onset autosomal dominant Alzheimer disease.